Filing Details
- Accession Number:
- 0000908662-15-000115
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-06 16:16:47
- Reporting Period:
- 2015-03-06
- Filing Date:
- 2015-03-06
- Accepted Time:
- 2015-03-06 16:16:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
907562 | Dyax Corp | DYAX | Services-Commercial Physical & Biological Research (8731) | 043053198 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1573163 | D. Andrew Ashe | C/O Dyax Corp. 55 Network Drive Burlington MA 01803-2756 | General Counsel & Evp | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-03-06 | 2,400 | $15.50 | 34,127 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan. The sales were primarily intended to provide liquidity sufficient to cover tax obligations due in connection with the vesting of restricted stock.